MILLENNIUM PARTNERS: Form 8.3 - Allergan plc
08 Mai 2020 - 4:15PM
UK Regulatory
TIDM0Y7T
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES
REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Millennium International Management LP
Company dealt in Allergan plc
Class of relevant security to which IE00BY9D5467
the dealings being disclosed relate
(Note 2)
Date of dealing 7(th) May 2020
2. INTERESTS AND SHORT POSITIONS
a. Interests and short positions (following dealing) in the
class ofrelevant security dealt in(Note 3)
Long Short
Number (%) Number (%)
(1) Relevant securities 4,462,367 2,705
(1.356%) (0.001%)
(2) Derivatives (other than options) - -
(3) Options and agreements to purchase/sell - -
Total 4,462,367 2,705
(1.356%) (0.001%)
b. Interests and short positionsin relevant securitiesof the
company, other than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
Ap20
1. DEALINGS (Note 4)
a. Purchases and sales
Price per unit (Note 5)
Purchase/sale Number of relevant securities (USD)
Purchase 177 193.75
Purchase 200 193.74
Purchase 100 193.83
Purchase 300 193.86
Purchase 99 193.76
Purchase 185 193.84
Purchase 100 193.67
Purchase 200 193.77
Sale 100 192.96
Purchase 100 193.80
Sale 50 193.03
Purchase 100 193.65
Sale 100 192.99
Purchase 100 193.82
Sale 50 193.02
Sale 200 192.97
Purchase 137 195.27
Purchase 97 194.93
Purchase 100 194.80
Purchase 2 194.61
Purchase 100 194.34
Purchase 500 194.11
Purchase 100 195.16
Purchase 1,601 193.75
Purchase 97 193.83
Purchase 200 195.18
Purchase 296 194.29
Purchase 399 194.41
Purchase 200 193.77
Purchase 213 193.24
Purchase 433 194.30
Purchase 100 192.91
Purchase 200 194.58
Purchase 198 194.90
Purchase 100 194.74
Purchase 1,184 194.07
Purchase 100 194.15
Purchase 299 193.96
Purchase 1,370 193.14
Purchase 100 192.87
Purchase 1,267 193.13
Purchase 696 192.92
Purchase 87 193.22
Purchase 1,337 193.15
Purchase 2,906 193.97
Purchase 100 194.10
Purchase 800 193.98
Purchase 200 193.73
Purchase 100 193.10
Purchase 200 193.08
Purchase 103 194.72
Purchase 100 193.81
Purchase 400 194.23
Purchase 66 193.07
Purchase 1,050 192.86
Sale 10,614 192.99
Purchase 400 194.09
Purchase 100 194.25
Purchase 998 193.12
Purchase 77 193.17
Purchase 300 194.14
Purchase 100 193.25
Purchase 248 193.11
Purchase 1,197 193.19
Purchase 266 193.92
Purchase 1,206 193.91
Purchase 2,020 193.09
Purchase 136 193.18
Purchase 131 192.84
Purchase 101 193.21
Purchase 1,903 194.03
Purchase 292 193.36
Purchase 574 193.44
Purchase 100 193.41
Sale 198 195.27
Purchase 198 192.99
Purchase 65 194.04
Sale 100 194.63
Purchase 100 194.31
Sale 100 194.64
Purchase 100 194.39
Purchase 100 194.19
Purchase 100 193.24
Sale 57 194.75
Purchase 2 193.14
Sale 121 192.96
Sale 557 193.13
Purchase 100 192.56
Purchase 33 193.22
Sale 139 193.03
Sale 20 192.95
Sale 43 192.90
Purchase 353 193.07
Sale 44 193.07
Purchase 100 193.05
Sale 100 193.39
Sale 1 193.12
Sale 67 193.17
Sale 100 193.25
Sale 1 193.40
Sale 300 193.00
Purchase 100 193.58
Sale 39 193.06
Sale 47 192.94
Sale 100 192.73
Sale 211 193.09
Sale 100 193.18
i. Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
b. Other dealings (including transactions in respect of new
securities) (Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options
or derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any other person relating to the
voting rights of any relevant securities under any option referred
to on this form or relating to the voting rights or future
acquisition or disposal of any relevant securities to which any
derivative referred to on this form is referenced. If none, this
should be stated.
None.
Is a Supplemental Form 8 attached? (Note 9) NO
Date of disclosure 8(th) May 2020
Contact name Milos Naumovic
Telephone number +44 203 650 8203
If a connected EFM, name of offeree/offeror with which
connected
If a connected EFM, state nature of connection (Note 10)
View source version on businesswire.com:
https://www.businesswire.com/news/home/20200508005281/en/
CONTACT:
Millennium Partners, L.P.
SOURCE: Millennium Partners, L.P.
Copyright Business Wire 2020
(END) Dow Jones Newswires
May 08, 2020 10:15 ET (14:15 GMT)
Allergan (LSE:0Y7T)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025
Allergan (LSE:0Y7T)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025
